This trial is studying adavosertib given with radiation therapy and temozolomide to see how well it works compared to radiation therapy and temozolomide alone in treating patients with newly diagnosed or recurrent glioblastoma.
3 Primary · 2 Secondary · Reporting Duration: Up to 2 years
Experimental Treatment
74 Total Participants · 2 Treatment Groups
Primary Treatment: Adavosertib · No Placebo Group · Phase 1
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: